http://etnet.com.hk/www/eng/stocks/realtime/quote_chart_interactive.php?code=2185 Web百心安生物 ,是中国领先的介入式心血管装置公司,目前专注于以下两种疗法: (i) 全降解支架 (BRS) ,以解决中国患者在治疗冠状或外周动脉疾病方面的未满足医疗需求;及 (ii) …
百心安生物,介入式心血管装置生物科技公司,递交招股书,拟香 …
WebBioheart is located in Shanghai, Shanghai, China. Who invested in Bioheart? Bioheart has 4 investors including BioVenture and CD Capital. How much funding has Bioheart raised to date? Bioheart has raised … WebDec 23, 2024 · Founded in 2013, Shanghai Golden Leaf Med Tec Co., Ltd is a high-tech enterprise specializing in the research and development of interventional diagnosis and treatment devices for hypertension and cancer pain. The RDN ablation system independently developed by the company won special approval for innovative medical … csk burn wet scrubber
百心安-B(02185)股票股价_股价行情_财报_数据报告 - 雪球
WebJan 11, 2024 · Bioheart availability is targeted for Q3 2024. Biotricity will showcase Bioheart at Pepcom’s Digital Experience during CES 2024 on January 11, 2024. For an advance look at Bioheart, watch this ... WebBio-heart (百心安) Shanghai, China. Medical Devices. 11 – 50. 1 investment. Bio-heart (百心安) is a medical device developer. Report. AD. Remove this ad space by ... Web百心安-B的最新评论 医药|【德邦医药】百心安Iberis达到主要临床终点事件点评. 一手投研V 今天 17:25 【德邦医药】百心安Iberis达到主要临床终点事件点评 [庆祝]4月11日,百心安发布公告,其用于治疗原发性高血压患者的肾动脉射频消融导管Iberis达到主要临床终点,试验结果表明,试验组于术后6个月 ... eagle lighter case